Objectives: Our purpose is to develop, implement and evaluate a research curriculum for pediatric trainees designed to improve research knowledge and skills. Background: Clinical Research is at the core of evidence-based practice. Health Services Research, Knowledge Transfer and Practice Audit are key features to establish and maintain good clinical practice. Pediatric residents and fellows must understand these features and become involved in research projects to acquire the knowledge, skills and competence to become better practitioners who are able to engage in their own research projects. Design/Methods: The Research Curriculum has been in place for 2 years: 2007-09. It is mandatory for all new paediatrics residents and offered to subspecialty residents and fellows. The curriculum includes the following components: 1) Formal Education (monthly) of clinical research /epidemiological fundamentals are presented by faculty members; each 3 hour session includes a lecture on health quality improvement/practice audit, followed by group discussion; 2) Journal Club (monthly) is structured to introduce and review key research methodologies and address important pediatric issues; 3) An Independent Research Project is a key component that should culminate in conference presentations and publications. At the midpoint of the research curriculum, trainees are solicited for feedback to assist with future planning and adjustments. Survey information collected from trainees identified their research background, attitudes towards research, baseline research knowledge, and areas of research interest. Results: All curriculum components were evaluated on an on-going basis. In Year 1 the new curriculum was well-accepted:1) Formal Education [91% Good or Very Good] 2) Journal Club [30% Excellent; 60% Very Good; 10% Good]. In Year 2 overall evaluation was similar to the first year: 1) Formal Education [7.5% Excellent; 87.5% Good or Very Good] 2) Journal Club [12% Excellent; 59% Very Good, 29% Good]. Results are summarized in Figure 1 .
Background: Atypical Teratoid Rhabdoid Tumour (ATRT) of the central nervous system (CNS) is a rare type of highly malignant embryonal neoplasm. A specific antibody test to detect loss or mutation of the INI-1 tumour suppressor gene (hSNF5/SMARCB1) has been used at BC Children's Hospital (BCCH) since 2007. Prior to the availability of this test, ATRT's could be indistinguishable from other tumours by routine pathology, and therefore may have been under-diagnosed. Objectives: We applied the INI-1 test retrospectively to determine how many CNS embryonal tumours over the prior two decades would be classified as an ATRT. Identifying 'cryptic' ATRT's allowed us to better describe the incidence and clinical outcomes for this unique tumour, which historically has been reported to have a dismal prognosis. Design/Method: With ethics approval, paraffin-embedded tissue was retrieved from storage for all BCCH patients from 1986 -2006 who were diagnosed with a CNS embryonal tumour. Slides were prepared and re-stained with the anti-BAF47/INI-1 antibody, and histologic features were reviewed. Results: Ninety-four patient samples were available, and INI-1 staining showed loss of retention in 12 samples (including 2 previously reported as ATRT without INI-1 testing). Median age at presentation was 1.3 years (0.3 -9 years), and there was a 9:3 female:male ratio. One patient was been treated with radiation, and 2 had metastatic disease. Median survival was only 14 months, but there were three long term survivors (4, 6, 8 years) without relapse. Revealing these 'cryptic' ATRT's changes the incidence of ATRT from 4% (1/25) to 36% (9/25) of all <3 year old patients with embryonal tumours between 1986 -2006. Conclusion: Previously there had been no reported survivors of ATRT at BCCH; by including our study findings, 25% of ATRT's actually had a survival rate greater than 3 years. Two were young patients treated with intensive chemotherapy and no radiation, showing promise for this strategy. A better understanding of how many children have actually had ATRT's and their corresponding survival rates is critical for designing more specific treatments in the future. Capturing ATRT as a separate entity inherently allows a more accurate reporting of survival rates for other CNS embryonal tumours.
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Objective: To determine how specific abnormal EEG findings found at 3 to 12 months correlate with clinical outcome on long term follow up. Material & method: This is a retrospective study of 358 term infants who had at least one EEG in the first year of life and subsequent clinical assessment between ages 4 to 16 years. Prognosis parameters included Epilepsy and Neurologic (intelligence, school performance, developmental milestones and neurological examination) outcomes. Long term prognosis was classified into "Normal" when patients had normal clinical outcome parameters, "Minor Sequelae" when patients had mild abnormalities in clinical outcome parameters, "Major Sequelae" when patients had moderate to severe abnormalities in clinical outcome parameters, and "Epilepsy" when patients had seizures and were on medication. 
